USA: A recent clinical trial has shown that Lorundrostat, a novel aldosterone synthase inhibitor, significantly lowers blood ...

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily ...

The Directorate General of Foreign Trade (DGFT), under the Ministry of Commerce and Industry, has issued Public Notice No. 03 ...

Ahmedabad: Zydus Lifesciences Limited has announced that the company has received final approval from the United States Food ...

According to a study published in the Annals of Family Medicinereports that using inhaled corticosteroids for more than 24 ...

A new study led by researchers at Yale University suggests that early-life exposure to two widespread environmental ...

At the recent SEC meeting for Ophthalmology held on 19th March 2025, the expert panel reviewed the proposal to conduct a ...

New Delhi- In less than a week, the National Testing Agency (NTA) is going to conduct the National Eligibility and Entrance ...

A new study published in the Journal of American Medical Association showed that Rilzabrutinib decreased itching and hives ...

Vadodara: Alembic Pharma, an Indian multinational pharmaceutical company, has announced that the Company has received an ...

Pakistan: A recent comparative study has shed light on the significant impact of obesity on joint replacement surgery ...

A new study led by researchers at Mass General Brigham suggests a nasal spray developed to target neuroinflammation could one ...